MediNiche’s BONE-TITE Is First Supplement for Dental Implant Patients


New OTC dietary supplement product developed in conjunction with dental professional experts in bone metabolism and bone growth for use with patients before and after dental implant procedures.

MediNiche’s BONE-TITE Is First Supplement for Dental Implant Patients

Described as the first osseointegration support supplement for dental implant patients, BONE-TITE is a new over-the-counter dietary supplement product developed in conjunction with prosthodontists, periodontists, and other dental professional experts in bone metabolism and bone growth for use with patients that may require nutritional insurance before and after dental implant procedures.

MediNiche, Inc, recently announced the introduction of BONE-TITE, which is formulated to provide key vitamins, minerals, and nutrients known to be helpful for proper bone and soft tissue growth, repair, and overall health during implant osseointegration.

The BONE-TITE formula is built around a “Bone-Building-Complex” of key ingredients associated with benefits to help heal, repair, and strengthen alveolar bone structure, according to the manufacturer. The formulation includes calcium, vitamins C, D-3 and K-1, and minerals magnesium, zinc, manganese, potassium and copper, and bone fortifying agents such as Ipriflavone, Bromelain, Boron, and L-Lysine.

The osseo-specific components in BONE-TITE may be helpful for patients that, due to deficiencies or underlying health issues, may be susceptible to reduced osseointegration and implant failure and may require or benefit from specific nutritional support.

Thomas J. Balshi, DDS, PhD, FACP, a leading implantologist and BONE-TITE advocate, states “When a regimen is started prior to an implant procedure, I believe BONE-TITE enhances osseointegration strength, even on the day implants are placed and continued use following the procedure helps support implant success. I recommend taking 3 tablets daily prior to surgery, then 3 tablets daily for 2 months following implant placement, then 2 tablets daily for 6 months, and 1 tablet daily thereafter.

BONE-TITE also has an improved tablet with a strong dissolution rate. A poor tablet dissolution rate can impede the absorption of calcium and other key nutrients. Many commercially available nutritional supplement tablets containing high levels of calcium have been proven to lack the dissolving characteristics necessary to allow proper calcium absorption by the body1.

Clinical and academic research have demonstrated that intake of key nutrients is directly related to oral and, specifically, alveolar and periodontal health. "Nutrition plays a key role in osseointegration," says Samuel Alioto, president and CEO, MediNiche. "In order to help ensure optimal osseointegration and soft tissue repair before and after implant placement, it is critical for patients to follow the pre- and post-procedure recommendations provided by their dental professional.

"With the introduction of BONE-TITE, dental professionals now have the option to provide implant patients with those nutrients that have demonstrated in well controlled clinical studies to be important to the health of alveolar bone.", says Aliot

BONE-TITE will be promoted to dental professionals for recommendation to patients before and after implant procedures. Patients will obtain the product from a dental practice during implant procedure orientation or with doctor recommendation. You can purchase the product online at, or by calling 888-325-2395.

MediNiche is extending a special BONE-TITE introductory offer with discount pricing and attractive terms available for all dental practice customers. Dental professionals can visit for more information.

1. Heaney RP, Recker RR, Hinders SM. Variability of calcium absorption. Am J Clin Nutr 1988;47:262-4
Recent Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
2024 Dental Products Report Spring Selection Bracket Reveal Video
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
Contemporary Cosmetic Dentistry – Part II: Arresting Marginal Caries
GNYDM23 Product Focus: CandidPro with Kristin Lange, VP of Sales at Candid
The Connected Future of Dental CAD/CAM with Max Milz
© 2024 MJH Life Sciences

All rights reserved.